Compare Kenvue Inc. Common Stock (KVUE) vs Boston Beer Company Inc (SAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kenvue Inc. Common Stock vs Boston Beer Company Inc — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Boston Beer Company Inc trades at $170.51 (market cap $1.76B). The key difference: Kenvue Inc. Common Stock is far larger — about 19.4× Boston Beer Company Inc's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Boston Beer Company Inc pays none. Which is the better fit depends on your goals.
| KVUE | SAM | |
|---|---|---|
Market Cap | $34.06B | $1.76B |
Volume | 23,267,228 | 264,496 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $19.83 | $260.05 |
52-Week Low | $14.11 | $161.08 |
Enterprise Value | $41.56B | $1.53B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 59 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Boston Beer Company (SAM) trades at $171.17, up 1.79% with a bullish technical signal despite recent earnings misses. The stock shows mixed fundamentals with a P/E of 22.66 and negative net margin of -3.64%, though operating cash flow remains strong at $270M. Recent news highlights brand innovation including new cocktail products and marketing partnerships, while analyst consensus leans heavily toward Hold with a $204.44 price target.
SAM faces headwinds from declining volumes and cost pressures, but brand investments and new product launches offer growth potential. The stock trades near analyst low targets with institutional interest growing, though profitability concerns and competitive pressures present significant risks for investors seeking turnaround opportunities in the challenging beverage sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kenvue Inc. Common Stock
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Read more on SAM →
